Three-dimensional systems in polybutylcyanoacrylate nanoparticles safety evaluation

International Journal of Polymeric Materials and Polymeric Biomaterials

Volumn 64, Issue 13, 2015, Pages 695-707

  Santos, Glaucia Cristina Mello ^a   Tiago, Manoela ^a   Maria Engler, Silvya Stuchi ^a   De Jesus Andreoli Pinto, Terezinha ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biocompatibility; Cell culture; Nanoparticle; Polybutylcyanoacrylate; Three dimensional

Indexed keywords

3D MODELING; BIOCOMPATIBILITY; CELL DEATH; DERMATOLOGY; FIBROBLASTS; MONOLAYERS; NANOPARTICLES; ONCOLOGY; PHYSIOLOGY; THREE DIMENSIONAL COMPUTER GRAPHICS;

CELL PHYSIOLOGY; NORMAL HUMAN FIBROBLAST; POLYBUTYLCYANOACRYLATE; SAFETY EVALUATIONS; THREE DIMENSIONAL SYSTEMS; THREE-DIMENSIONAL (3D) CELL CULTURE; TIME DEPENDENT; TYPE I COLLAGEN;

CELL CULTURE;

EID: 84928038983     PISSN: 00914037     EISSN: 1563535X     Source Type: Journal    
DOI: 10.1080/00914037.2014.1002097     Document Type: Article

References (47)

1. Nair, L. S.; Laurencin, C. T. Biodegradable polymers as biomater-ials. Prog. Polym. Sci. 2007, 32, 762-798.
2. Reszka, R.; Beck, P.; Fichtner, I.; Hentschel, M.; Richter, J.; Kreuter, J. Body distribution of free, liposomal and nanoparticle-associated mitoxantrone in B16-melanoma-bearing mice. J. Pharmacol. Exp. Ther. 1997, 280, 232-237.
3. Zhang, Z.-R.; Qin, H. Study on liver targeting and hepatocytes permeable valaciclovir polybutylcyanoacrylate nanoparticles. World J. Gastroenterol. 1999, 5, 330-333.
4. Zhang, Z.; Yang, X.; Deng, S.; Xu, W.; Gao, H. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice. Chin. Med. J. 2007, 120, 1336-1342.
5. Ren, F.; Chen, R.; Wang, Y.; Sun, Y.; Jiang, Y.; Li, G. Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer. Pharm. Res. 2011, 28, 897-906.
6. Shahmabadi, H. E.; Movahedi, F.; Esfahani, M. K. M.; Alavi, S. E.; Eslamifar, A.; Anaraki, M.; Akbarzadeh, A. Efficacy of cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma. Tumor. Biol. 2014, 35, 4799-4806.
7. Olivier, J.-C. Drug transport to brain with targeted nanoparticles. NeuroTherapeutics 2005, 2, 108-119.
8. Zhao, L.; Liu, A.; Yu, S.; Wang, Z.; Lin, X.; Zhai, G.; Zhang, Q. The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury. Biol. Pharm. Bull. 2013, 36, 1263-1270.
9. Chiellini, F. Perspectives on: in vitro evaluation of biomedical polymers. J. Bioact. Compat. Polym. 2006, 21, 257-271.
10. Tsang, V. L.; Bhatia, S. N. Fabrication of three-dimensional tissues. Adv. Biochem. Eng. Biotechnol. 2006, 103, 189-205.
11. Petersen, M. C.; Lazar, J.; Jacob, H. J.; Wakatsuki, T. Tissue engineering: a new frontier in physiological genomics. Physiol. Genomics 2007, 32, 28-32.
12. Ye, F.; Barrefelt, A.; Asem, H.; Abedi-Valugerdi, M.; El-Serafi, I.; Saghafian, M.; Abu-Salah, K.; Alrokayan, S.; Muhammed, M.; Hassan, M. Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging. Biomaterials 2014, 35, 3885-3894.
13. Kim, J.-E.; Yoon, I.-S.; Cho, H.-J.; Kim, D.-H.; Choi, Y.-H.; Kim, D.-D. Emulsion-based colloidal nanosystems for oral delivery of doxorubicin: Improved intestinal paracellular absorption and alleviated cardiotoxicity. Int. J. Pharm. 2014, 464, 117-126.
14. Termsarasab, U.; Yoon, I.-S.; Park, J.-H.; Moon, H.-T.; Cho, H.-J.; Kim, D.-D. Polyethylene glycol-modified arachidyl chitosan-based nanoparticles for prolonged blood circulation of doxorubicin. Int. J. Pharm. 2014, 464, 127-134.
15. Hu, X.; Tulsieram, K. L.; Zhou, Q.; Mu, L.; Wen, J. Polymeric nanoparticle-aptamer bioconjugates can diminish the toxicity of mercury in vivo. Toxicol. Lett. 2012, 208, 69-74.
16. Couvreur, P.; Roland, M.; Speiser, P. Biodegradable submicroscopic particles containing a biologically active substance and compositions containing them. U.S. Patent No. 4,329,332, 1982.
17. Couvreur, P.; Kante, B.; Roland, M.; Guiot, P.; Bauduin, P.; Speiser, P. Polycyanoacrylate nanocapsules as potencial lysosomo-tropic carriers: preparation, morphological and sortptive properties. J. Pharm. Pharmacol. 1979, 31, 331-332.
18. Vauthier, C.; Dubernet, C.; Fattal, E.; Pinto-Alphandary, H.; Couvreur, P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv. Drug Deliv. Rev. 2003, 55, 519-548.
19. Brzoska, M.; Langer, K.; Coester, C.; Loitsch, S.; Wagner, T. O. F.; Mallinckrodt, C. V. Incorporation of biodegradable nanoparti-cle into human airway epithelium cells - in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases. Biochem. Biophys. Res. Co. 2004, 318, 562-570.
20. Fernadez-Urrusuno, R.; Fattal, E.; Porquet, D.; Feger, J.; Couvreur, P. Evaluation of liver toxicological effects induced by polyalkylcyanoacrylate nanoparticles. Toxicol. Appl. Pharm. 1995, 130, 272-279.
21. Maksimenko, O.; Pavlov, E.; Toushov, E.; Molin, A.; Stukalov, Y.; Prudskova, T.; Feldman, V.; Kreuter, J.; Gelperina, S. Radiation sterilization of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles. Int. J. Pharm. 2008, 356, 325-332.
22. Vauthier, C.; Dubernet, C.; Chauvierre, C.; Brigger, I.; Couvreur, P. Drug delivery to resistant tumors the potencial of poly(alkyl cyanoacrylate) nanoparticles. J. Control. Release 2003, 93, 151-160.
23. Wong, J. Y.; Bronzino, J. D. Biomaterials; CRC Press, Boca Raton, FL, 2007.
24. Liu, Z.; Wu, X. Y.; Bendayan, R. In vitro investigation of ionic polysaccharide microspheres for simultaneous delivery of chemo-sensitizer and antineoplastic agent to multidrug-resistant cells. J. Pharm. Sci. 1999, 88, 412-418.
25. Berridge, M. V.; Tan, A. S. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys. 1993, 303, 474-482.
26. Ciapetti, G.; Cenni, E.; Pratelli, L.; Pizzoferrato, A. In vitro evaluation of cell/biomaterial interaction by MTT assay. Biomaterials 1993, 14, 359-364.
27. Bell, E.; Ivarsson, B.; Merrill, C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc. Natl. Acad. Sci. USA 1979, 76, 1274-1278.
28. Boggio, R. F.; Freitas, V. M.; Paggiaro, A. O.; Herson, M. R.; Ferreira, M. C.; Machado-Santelli, G. M. Estudo in vitro dos efeitos do bloqueador do canal decálcio (verapamil) sobre a bioss̈intese e con-tracão da matriz extracelular. Rev. Bras. Cir. Plást. 2009, 24, 91-95.
29. Ehrlich, H. P. Wound closure: evidence of cooperation between fibroblasts and collagen matrix. Eye 1988, 2, 149-157.
30. Lee, J.; Lilly, D.; Doty, R. C.; Podsiadlo, P.; Kotov, N. A. In vitro toxicity testing of nanoparticles in 3D cell culture. Small 2009, 5, 1213-1221.
31. Tiago, M. Prospeccão de novos fármacos para melanoma em equivalente dérmico. Dissertacão de Mestrado - Faculdade de Ciências Farmacêuticas - Universidade de São Paulo, São Paulo, 2011. http://www.teses.usp.br/teses/disponiveis/9/9136/tde-05082011-170530/pt-br.php. (Accessed 16 July 2014).
32. Pisanic, T. R. II; Blackwell, J. D.; Shubayev, V. I.; Fiñones, R. R.; Jin, S. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 2007, 28, 2572-2580.
33. Magraz, A.; Kasas, S.; Salicio, V.; Pasquier, N.; Seo, J. W.; Celio, M.; Catsicas, S.; Schwaller, B.; Forro, L. Cellular toxicity of carbon-based nanomaterials. Nano Lett. 2006, 6, 1121-1125.
34. Sayes, C. M.; Fortner, J. D.; Guo, W.; Lyon, D.; Boyd, A. M.; Ausman, K. D.; Tao, Y. J.; Sitharaman, B.; Wilson, L. J.; Hughes, J. B.; West, J. L.; Colvin, V. L. The differential cytotoxicity of water-soluble fullerenes. Nano Lett. 2004, 4, 1881-1887.
35. Kim, J. S.; Yoon, T.-J.; Yu, K. N.; Kim, B. G.; Park, S. J.; Kim, H. W.; Lee, K. H.; Park, S. B.; Lee, J.-K.; Cho, M. H. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol. Sci. 2006, 89, 338-347.
36. Sayes, C. M.; Marchione, A. A.; Reed, K. L.; Warheit, D. B. Comparative pulmonary toxicity assessments of C60 water suspensions in rats: Few differences in fullerene toxicity in vivo in contrast to in vitro profiles. Nano. Lett. 2007, 7, 2399-2406.
37. Zhang, Y.; Chen, W.; Zhang, J.; Liu, J.; Chen, G.; Pope, C. In vitro and in vivo toxicity of CdTe nanoparticles. J. Nanosci. Nanotechnol. 2007, 7, 497-503.
38. Couvreur, P.; Vauthier, C. Polyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectives. J. Control. Release 1991, 17, 187-198.
39. Lee, J.; Cuddihy, M. J.; Kotov, N. A. Three-dimensional cell culture matrices: state of the art. Tissue Eng. Part B 2008, 14, 61-86.
40. Rubinsztein, D. C.; Gestwicki, J. E.; Murphy, L. O.; Klionsky, D. J. Potential therapeutic applications of autophagy. Nat. Ver. Drug Discov. 2007, 6, 304-312.
41. Massaro, R. R. Efeito do 4-nerolidilcatecol na citotoxicidade e inibica&tild; o de invasa&tild;o nas linhagens de glioma humano A172 e T98G. Dissertaca&tild;o de Mestrado - Faculdade de Ciências Farmacêuticas - Universidade de Sa&tild;o Paulo, Sa&tild;o Paulo, 2009. http://www.teses.usp.br/teses/ disponiveis/9/9136/tde-29092009-154905/pt-br.php. (Accessed 16 July 2014).
42. Schaffazick, S. R.; Guterres, S. S.; Freitas, L. L.; Pohlmann, A. R. Caracterizaca&tild;o e estabilidade fi´sico-qui´mica de sistemas polime´ri-cos nanoparticulados para a administraca&tild;o de fa´rmacos. Qui´m. Nova 2003, 26, 726-737.
43. Jones, C. F.; Grainger, D. W. In vitro assessments of nanomaterial toxicity. Adv. Drug Deliv. Rev. 2009, 61, 438-456.
44. Fang, C.; Sui, B.; Pei, Y.; Hong, M.; Wu, J.; Chen, H. In vivo tumor targeting of tumor necrosis factor-a-loaded stealth nanopar-ticles: Effect of MePEG molecular weight and particle size. Eur. J. Pharm. Sci. 2006, 27, 27-36.
45. Alexis, F.; Pridgen, E.; Molnar, L.; Farokhzad, O. C. Factors affecting the clearance and biodistribution of polymeric nanoparti-cles. Mol. Pharm. 2008, 5, 505-515.
46. Kane, R. S.; Stroock, A. D. Nanobiotechnology: protein-nanomaterial interactions. Biotechnol. Prog. 2007, 23, 316-319.
47. Mosqueira, V. C. F.; Legrand, P.; Pinto-Alphandary, H.; Puisieux, F.; Barratt, G. Poly(D,L-lactide) nanocapsules prepared by a solvent displacement process: influence of the composition on physicochemical and structural properties. J. Pharm. Sci. 2000, 89, 614-626.